About MENINBLOX

MENINBLOX is a medical AI company founded in 2022. Built on MediKoGPT, our medical language model, we make services for medical-record summarization, AI patient intake, international-care interpretation, and exercise and pain coaching.

Medical AI whose evidence clinicians can check.

Company overview

  • 6Partner hospitals in Korea, including Seoul National University Hospital
  • 4Countries abroad: Indonesia, Kazakhstan, Philippines, Estonia
  • 96.98%MediKoGPT diagnosis prediction accuracy (TTA test)
  • GMPLicensed digital medical device manufacturer, GMP certified
CEO
Benjamin Park
Founded
June 21, 2022
People
14
Field
Medical AI software, digital medical devices
Certifications
Digital medical device manufacturing license · Digital medical device GMP · ISO/IEC 27001 · GS Grade 1 · Innovative growth venture
R&D centers
MENINBLOX Content Lab (Gwangju) · Medical AI Research Lab (Seoul)
Locations

Head office · Unit 214, 339 Cheomdangwagi-ro, Buk-gu, Gwangju, Republic of Korea

GMP facility · Unit A-1204, 45 Ipchun-ro, Wonju-si, Gangwon-do

Research Lab · Unit B-1502, Munjeong Station Terra Tower, 167 Songpa-daero, Songpa-gu, Seoul

What we build

Each product lists the hospitals and institutions where it is deployed or validated.

  • Medical-record AIAilix Note

    Reads referral letters, test reports and discharge summaries, summarizes them and links every point to its source.

    Deploying at Seoul National University Hospital and SNU Bundang Hospital; joint research with Inha University Hospital

  • International careAilix Suite

    Translates and summarizes records and intake answers submitted by overseas patients, and checks for mistranslated numbers, drugs and units. Ailix Suite supports 12 languages. It uses MedicaVox to interpret chat, voice and video.

    Co-developed with International St. Mary's Hospital; hospitals in Indonesia, Kazakhstan and the Philippines

  • AI patient intakeMediKoGPT

    Conversational pre-visit intake for gastrointestinal diseases and neurological symptoms such as headache and dizziness.

    Clinical validation and delivery at Hallym University Chuncheon Sacred Heart Hospital; co-development with Chonnam National University Hospital

  • Medical educationAilix CPX

    Medical students practice clinical performance examinations (CPX) by interviewing AI virtual patients.

    Exhibited at CES 2026; cooperation with Saint Louis University Hospital, Philippines

  • Exercise and pain coachingRoopin

    Combines wearable data with pain check-ins to suggest whether to run, rest or ease off today.

    Launched June 2026; validation in Estonia and Indonesia

Research

Papers written with our clinical advisors. In June 2026 we published a Korean symptom-triage dataset of 6,912 cases labeled with ICD-10 differential diagnoses.

  • Computers in Biology and Medicine, Vol. 200

    Hierarchical RAG Enhances a Pharmacogenomic AI Assistant in Guideline-related Queries

  • Journal of Medical Internet Research, Vol. 26

    Large Language Models in Gastroenterology: Systematic Review

  • Bioengineering, 12(1)

    The Potential Clinical Utility of the Customized Large Language Model in Gastroenterology: A Pilot Study

History

Contracts, joint research, selections and awards since we were founded in 2022.

2026

11
  • Winner of the National Assembly Trade, Industry, Energy, SMEs and Startups Committee Chairman's Award at the 2026 Korea SME Innovation Awards
10
  • Began deploying Ailix Note, our medical-record summarization AI, at Seoul National University Hospital and SNU Bundang Hospital (delivery in December 2026)
  • International St. Mary's Hospital opened separate telemedicine centers at Mangystau Regional Hospital and Atyrau Regional Children's Hospital in Kazakhstan. Ailix supports remote care in Atyrau.
  • Selected for the Regulation-Free Special Zone open-innovation program: EMR-linked AI pre-visit questionnaires and early-warning detection
  • Roopin joined the Samsung Health Data SDK and Samsung Health Sensor SDK partner programs
09
  • Agreed with Saint Louis University's hospital in the Philippines to cooperate on Ailix CPX and international telemedicine
07
  • Signed a validation contract and MOU with Metrosert, Estonia's national metrology institute, to test Roopin
06
  • Launched Roopin, our AI running companion, on iOS and Android
  • Signed an MOU with Upstage on EMR AI for hospitals
  • Signed a cooperation agreement with Inha University Hospital (through 2028)
05
  • Signed Ailix telemedicine cooperation agreements with hospitals in Kazakhstan, together with International St. Mary's Hospital
  • Signed a joint international-care research agreement with JARQYN, a health-screening operator in Kazakhstan
  • Commendation from the Minister of Intellectual Property for promoting invention
04
  • Began the Ministry of Health and Welfare's ICT healthcare overseas expansion program with International St. Mary's Hospital (Indonesia)
01
  • Took charge of Ailix telemedicine in the cooperation between International St. Mary's Hospital and Prof. Dr. I.G.N.G. Ngoerah Hospital, Indonesia
  • Exhibited Ailix CPX, our clinical-skills training tool, at CES 2026 (second consecutive CES)

2025

11
  • Commendation from the Minister of SMEs and Startups
  • Commendation from the Mayor of Wonju for advancing high-tech industry
  • ISO/IEC 27001 information security management certification
  • MediKoGPT v1.0, our medical language model, received TTA Good Software (GS) Grade 1 certification
  • Delivered an LLM-based interactive program for children with developmental disabilities to Inha University Hospital
10
  • Digital medical device GMP certification from the Ministry of Food and Drug Safety
  • Delivered an LLM-based international-care interpretation solution to International St. Mary's Hospital
09
  • Delivered an LLM-based gastrointestinal intake solution to Hallym University Chuncheon Sacred Heart Hospital
  • Commendation from the chair of the Presidential Committee on Balanced National Development
07
  • Chosun University's Department of Biotechnology and Multimodal Genomics Launch Joint Research
06
  • Inha University Hospital Signs Agreement to Develop LLM-Based Interactive Program for Developmentally Disabled Children
  • Received the President's Award from the Korea Institute of Startups and Entrepreneurship Development
  • Licensed as a digital medical device manufacturer by the Ministry of Food and Drug Safety
05
  • Hanam City Mental Health and Welfare Center Signs Contract to Develop LLM-Based Slow Learner Education Program
  • Suhi-Tech Tokyo 2025 Announces Sleep Care Exhibition
04
  • Hallym University Chuncheon Sacred Heart Hospital Signs Contract to Supply LLM-Based Questionnaire Solution
03
  • International St. Mary's Hospital to Provide LLM-Based International Medical Interpreting Solution
02
  • AI Voucher Support Project Supplier Selection
01
  • Confirmation of innovative growth type venture companies
  • Participating in the CES 2025 Seoul Integrated Pavilion Exhibition
  • TIPS R&D Support Project Final Selection
  • Opened the Medical AI Research Lab in Seoul (accredited corporate R&D center)

2024

12
  • Winner of the Entrepreneurship Promotion Center Director's Award from the Entrepreneurship-focused University
11
  • Selected for the Ministry of SMEs and Startups "TIPS R&D" support project
  • Chonnam National University Hospital begins development of AI questionnaire for neurological diseases.
10
  • MediKoGPT selected for global expansion support project
08
  • Winner of the Ministry of SMEs and Startups Welcome to Tips IR Demo Day Encouragement Award
07
  • IBK Changgong Gwangju 1st batch selection
06
  • Kibo Venture Camp Final Demo Day Excellence Award Winner
05
  • Development of a biosignal-based emotional support management platform for infertile and pregnant women.
04
  • Selected as a Global Medical AI Demonstration Special Case Company (Gangwon Province)
  • Development of an AI questionnaire solution for identifying the causes of headaches and dizziness.

2023

07
  • Development of a core technology, an AI-based digestive disease screening solution, has begun.

2022

08
  • Gwangju Special Zone Accelerating Excellence Award
06
  • Establishment of Man in Block Corporation

Talk to us about product adoption, research or partnerships

We reply by email within 1 business day.